Syntrix Pharmaceuticals

Pre-clinical

Auburn, United StatesFounded 2000syntrixbio.com

Develops small molecule therapeutics targeting cancer and inflammatory diseases.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $4.3M

Develops small molecule therapeutics targeting cancer and inflammatory diseases.

Small Molecules

Total raised:$4.3M

Grant$2.5MNational Institutes of HealthSep 15, 2021

Grant$1.8MNational Institute of Neurological Disorders and StrokeMay 15, 2020